[
  {
    "ts": null,
    "headline": "Becton, Dickinson and Company's (NYSE:BDX) Intrinsic Value Is Potentially 66% Above Its Share Price",
    "summary": "Key Insights The projected fair value for Becton Dickinson is US$322 based on 2 Stage Free Cash Flow to Equity Becton...",
    "url": "https://finnhub.io/api/news?id=3724c544cda66ed230ac7a180b3d6765a057ec4eab9231afb2eb194492800cd5",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1764327616,
      "headline": "Becton, Dickinson and Company's (NYSE:BDX) Intrinsic Value Is Potentially 66% Above Its Share Price",
      "id": 137628487,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BDX",
      "source": "Yahoo",
      "summary": "Key Insights The projected fair value for Becton Dickinson is US$322 based on 2 Stage Free Cash Flow to Equity Becton...",
      "url": "https://finnhub.io/api/news?id=3724c544cda66ed230ac7a180b3d6765a057ec4eab9231afb2eb194492800cd5"
    }
  },
  {
    "ts": null,
    "headline": "North America Nucleic Acid Amplification Testing Market Analysis Report 2025-2033 - Technological Advances, Rising Diagnostic Demand, and Widespread Applications",
    "summary": "The North American Nucleic Acid Amplification Testing (NAAT) market will reach $7.64 billion by 2033, growing from $3.28 billion in 2024 with a CAGR of 9.87%. Driven by technological advances, rising diagnostic demand, and widespread applications, NAAT proves critical in identifying infectious diseases and genetic mutations. Notably, innovation, automation, and government support bolster the market's expansion. Despite regulatory hurdles and high costs, ongoing collaborations aim to enhance affo",
    "url": "https://finnhub.io/api/news?id=f7a7e7b94016b47ec8b00b5f18596da0ab3f225f7ebb215af000e0743e4467e5",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1764320760,
      "headline": "North America Nucleic Acid Amplification Testing Market Analysis Report 2025-2033 - Technological Advances, Rising Diagnostic Demand, and Widespread Applications",
      "id": 137628186,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BDX",
      "source": "Yahoo",
      "summary": "The North American Nucleic Acid Amplification Testing (NAAT) market will reach $7.64 billion by 2033, growing from $3.28 billion in 2024 with a CAGR of 9.87%. Driven by technological advances, rising diagnostic demand, and widespread applications, NAAT proves critical in identifying infectious diseases and genetic mutations. Notably, innovation, automation, and government support bolster the market's expansion. Despite regulatory hurdles and high costs, ongoing collaborations aim to enhance affo",
      "url": "https://finnhub.io/api/news?id=f7a7e7b94016b47ec8b00b5f18596da0ab3f225f7ebb215af000e0743e4467e5"
    }
  }
]